ACQUIRED RESISTANCE TO IMMUNE CHECKPOINT BLOCKADE BY PHENOTYPIC PLASTICITY OF MELANOMA

被引:0
|
作者
Robitschek, Emily [1 ]
Mehta, Arnav [2 ]
Lin, Jia-Ren [3 ]
Frederick, Dennie [4 ]
Shi, Alvin [5 ]
Larque, Ana [6 ]
Miao, Benchun [2 ]
Raghavan, Rumya [7 ]
Sharova, Tatyana [2 ]
Shin, John [2 ]
Kellis, Manolis [5 ]
Hacohen, Nir [4 ]
Flaherty, Keith [2 ]
Boland, Genevieve [2 ]
Chebib, Ivan [2 ]
Liu, David [1 ]
Sullivan, Ryan [2 ]
机构
[1] Dana Farber Canc Inst, Boston, MA 02115 USA
[2] Massachusetts Gen Hosp, Boston, MA 02114 USA
[3] Harvard Med Sch, Boston, MA 02115 USA
[4] Broad Inst MIT & Harvard, Cambridge, MA 02142 USA
[5] MIT, Boston, MA USA
[6] Hosp Clin Barcelona, Barcelona, Spain
[7] Broad Inst Harvard & MIT, Cambridge, MA USA
关键词
D O I
10.1136/jitc-2022-SITC2022.0916
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
916
引用
收藏
页码:A955 / A955
页数:1
相关论文
共 50 条
  • [41] Immune checkpoint blockade in melanoma by new targeted Dox immunoliposomes
    Merino Diaz, M.
    Contreras Sandoval, A. M.
    Berraondo, K.
    Garrido Cid, M. J.
    EUROPEAN JOURNAL OF CANCER, 2016, 55 : S18 - S19
  • [42] The concepts of rechallenge and retreatment with immune checkpoint blockade in melanoma patients
    Zaremba, Anne
    Eggermont, Alexander M. M.
    Robert, Caroline
    Dummer, Reinhardt
    Ugurel, Selma
    Livingstone, Elisabeth
    Ascierto, Paolo A.
    Long, Georgina, V
    Schadendorf, Dirk
    Zimmer, Lisa
    EUROPEAN JOURNAL OF CANCER, 2021, 155 : 268 - 280
  • [43] Immune-related pancreatitis associated with checkpoint blockade in melanoma
    Kohlmann, Johannes
    Wagenknecht, Daniel
    Simon, Jan-Christoph
    Ziemer, Mirjana
    MELANOMA RESEARCH, 2019, 29 (05) : 549 - 552
  • [44] Opportunities for Discovery Using Neoadjuvant Immune Checkpoint Blockade in Melanoma
    Nair, Uma
    Rakestraw, Emily
    Beasley, Georgia M.
    O'Connor, Margaret H.
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (06)
  • [45] Multimodal real world data reveals immunogenomic drivers of acquired and primary resistance to immune checkpoint blockade
    Keddar, Mohamed Reda
    Pro, Sebastian Carrasco
    Burke, Kathleen
    Stewart, Ana Camelo
    Cobbold, Mark
    Stewart, Ross
    Khosla, Sajan
    Sidders, Ben
    Hammond, Scott
    Palmer, Douglas C.
    Dry, Jonathan
    Miller, Martin L.
    CANCER RESEARCH, 2024, 84 (06)
  • [46] Primary and Acquired Resistance to Immunotherapy in Lung Cancer: Unveiling the Mechanisms Underlying of Immune Checkpoint Blockade Therapy
    Boyero, Laura
    Sanchez-Gastaldo, Amparo
    Alonso, Miriam
    Francisco Noguera-Ucles, Jose
    Molina-Pinelo, Sonia
    Bernabe-Caro, Reyes
    CANCERS, 2020, 12 (12) : 1 - 36
  • [47] Immune biomarkers for prognosis and prediction of responses to immune checkpoint blockade in cutaneous melanoma
    Jacquelot, Nicolas
    Pitt, Jonathan M.
    Enot, David P.
    Roberti, Maria Paula
    Duong, Connie P. M.
    Rusakiewicz, Sylvie
    Eggermont, Alexander M.
    Zitvogel, Laurence
    ONCOIMMUNOLOGY, 2017, 6 (08):
  • [48] Tumour-intrinsic resistance to immune checkpoint blockade
    Anusha Kalbasi
    Antoni Ribas
    Nature Reviews Immunology, 2020, 20 : 25 - 39
  • [49] Tumour-intrinsic resistance to immune checkpoint blockade
    Kalbasi, Anusha
    Ribas, Antoni
    NATURE REVIEWS IMMUNOLOGY, 2020, 20 (01) : 25 - 39
  • [50] Hallmarks of response, resistance, and toxicity to immune checkpoint blockade
    Morad, Golnaz
    Helmink, Beth A.
    Sharma, Padmanee
    Wargo, Jennifer A.
    CELL, 2021, 184 (21) : 5309 - 5337